What is solar urticaria?
Solar urticaria is a rare form of chronic inducible urticaria in which exposure to sunlight — or in some cases artificial light sources — triggers the immediate development of hives on exposed skin. It is one of the more clinically significant photosensitivity conditions because of its potential to cause systemic reactions including anaphylaxis, and because even brief, everyday sun exposure can produce debilitating symptoms in severely affected individuals.
Unlike polymorphous light eruption — the most common sun-related skin condition — solar urticaria produces an immediate reaction developing within minutes of light exposure rather than hours later. And unlike most photosensitivity conditions, solar urticaria can in severe cases be triggered through window glass and lightweight clothing by visible light wavelengths rather than UV alone, making avoidance considerably more challenging.
The mechanism of solar urticaria is thought to involve the formation of a photoallergen — a skin-derived substance that is created or modified by light exposure and then triggers mast cell degranulation and histamine release in sensitized individuals. This mechanism shares features with both allergic and physical urticaria and explains the rapid onset of hives and the potential for systemic histamine-mediated symptoms. Whether a true IgE-mediated immune response is involved or a direct mast cell activation pathway is the primary driver remains an area of ongoing research.
Solar urticaria is significantly more common in women than men and most commonly presents in young to middle-aged adults, though it can develop at any age. It is a chronic condition — defined as persisting for more than six weeks — and tends to run a prolonged course, though spontaneous remission does occur in a proportion of patients over years.
Solar urticaria sits within the broader category of sun allergy conditions. If you are uncertain which type of sun-related reaction you are experiencing, our sun allergy overview page provides a guide to distinguishing between the different conditions in this group.
Symptoms
Solar urticaria symptoms develop rapidly — typically within one to three minutes of light exposure and almost always within ten minutes. They are confined initially to the light-exposed skin areas but can extend systemically in more severe reactions.
Local skin symptoms:
- Itching, burning, or stinging of the exposed skin — often the first symptom, developing within seconds to minutes
- Redness and flushing of exposed skin
- Hives (wheals) on the exposed skin areas — typically small to medium-sized, well-defined, and intensely itchy
- Swelling at the exposed site
Systemic symptoms (in more severe reactions):
- Widespread hives beyond the exposed area
- Headache and dizziness
- Nausea
- Wheezing or difficulty breathing
- Throat tightening
- Drop in blood pressure
- Anaphylaxis
- Loss of consciousness in extreme cases
Symptoms typically resolve within one to two hours after the light source is removed and the skin is shielded — a relatively rapid resolution that distinguishes solar urticaria from most other photosensitivity conditions where reactions persist for hours to days.
The risk of systemic reactions is related to the total body surface area exposed to light. Exposure of a small area — a forearm, for example — typically produces only local hive formation, while extensive exposure such as swimming outdoors or sunbathing can expose enough body surface area to trigger significant systemic histamine release and anaphylaxis. This relationship between body surface area and systemic reaction risk is an important feature for patients to understand when planning sun exposure management.
Action spectrum and light sensitivity
The specific wavelengths of light responsible for triggering solar urticaria — known as the action spectrum — vary between individuals and have important implications for management.
Most individuals with solar urticaria react to ultraviolet A (UVA, 315–400nm) and/or ultraviolet B (UVB, 280–315nm) wavelengths. Some individuals also react to visible light wavelengths (400–700nm). The distinction matters clinically because:
- Standard sunscreens provide good protection against UVB and reasonable protection against UVA, but offer no protection against visible light
- Window glass blocks UVB but transmits most UVA and essentially all visible light — individuals with visible light sensitivity can react indoors near windows or in cars
- Lightweight clothing transmits visible light and may not provide adequate protection for individuals sensitive to these wavelengths
- Phototesting to determine individual action spectrum is therefore essential for guiding which protective measures will actually be effective
Diagnosis
Clinical history
A detailed history of the timing, distribution, and nature of skin reactions in relation to sun or light exposure is the starting point. Your physician will assess how quickly hives develop after exposure, which body areas are affected, whether reactions occur through glass or clothing, whether artificial light sources including fluorescent and LED lighting have triggered reactions, and whether systemic symptoms have occurred. A history of reactions developing within minutes of sun exposure and resolving within one to two hours after sun avoidance is a characteristic presentation that points strongly toward solar urticaria.
Phototesting
Phototesting is the key diagnostic procedure for solar urticaria and is performed in specialist allergy or dermatology settings. Controlled doses of UV and visible light at specific wavelengths are delivered to a small area of unexposed skin — typically the inner forearm or back — using a monochromator or solar simulator. The response is observed over the following 10 to 30 minutes.
A positive test produces wheals at the irradiated site within minutes, confirming the diagnosis and identifying the minimal urticarial dose — the lowest light dose that produces a reaction — and the action spectrum — the specific wavelengths responsible. Both pieces of information are important for guiding management, particularly the selection of photoprotective measures and hardening therapy protocols.
Differentiation from other conditions
Solar urticaria must be distinguished from other forms of chronic inducible urticaria — particularly aquagenic urticaria, cholinergic urticaria, and heat urticaria — as well as from polymorphous light eruption and photoallergic contact dermatitis. The immediate onset of hives specifically in response to light exposure — rather than heat, water, or exercise — and the resolution within one to two hours of sun avoidance are the features most specific to solar urticaria.
Blood tests
Routine blood testing is not diagnostic for solar urticaria but may be ordered to exclude underlying conditions associated with photosensitivity, including lupus erythematosus and erythropoietic protoporphyria, which can present with some similar features.
Treatment
Solar urticaria is a chronic condition for which there is currently no cure, but symptoms can be managed effectively in many patients through a combination of photoprotection, pharmacological treatment, and in some cases hardening therapy or biologic medication.
Photoprotection
Reducing light exposure to below the individual’s minimal urticarial dose is the primary environmental management strategy. The specific approach depends on the action spectrum identified through phototesting.
- Broad-spectrum sunscreen with SPF 50 or higher applied generously to all exposed skin — most effective for UVB and UVA-sensitive individuals; provides little protection for visible light-sensitive individuals
- Sun-protective clothing with a high ultraviolet protection factor (UPF) rating
- Wide-brimmed hats and UV-protective sunglasses
- UV-blocking window film for car and home windows — particularly important for individuals with UVA or visible light sensitivity who can react indoors
- Avoiding peak UV hours where possible
- Tinted or pigmented sunscreens containing iron oxides provide some protection against visible light wavelengths for individuals with visible light sensitivity
Antihistamines
Second-generation H1 antihistamines are the first-line pharmacological treatment for solar urticaria. High-dose regimens — up to four times the standard dose — are sometimes required for adequate symptom control and may be used under physician supervision. Consistent daily use is more effective than taking antihistamines on demand, as pre-treating before anticipated sun exposure helps suppress the mast cell response. For individuals with frequent sun exposure, taking antihistamines 30 to 60 minutes before going outdoors can provide additional benefit.
Omalizumab
Omalizumab — a biologic medication that targets IgE and is approved for chronic spontaneous urticaria — has been used off-label with well-documented success in solar urticaria cases that do not respond adequately to antihistamines. Multiple case series and reports have demonstrated significant reductions in symptom severity and improvements in tolerance of sun exposure in solar urticaria patients treated with omalizumab. It represents an important treatment option for individuals with refractory disease and should be discussed with an allergist when standard antihistamine therapy is insufficient.
Hardening therapy
Hardening therapy — also known as phototherapy or phototolerance induction — involves controlled, repeated exposure to gradually increasing doses of UV light in a clinical setting, with the goal of raising the individual’s minimal urticarial dose and improving tolerance of everyday sun exposure. It is typically administered as narrowband UVB phototherapy or PUVA (psoralen plus UVA) under medical supervision. The protective effect of hardening therapy is temporary and requires regular maintenance exposures to sustain, and it is not effective for all patients, but it can provide meaningful improvement in tolerance for those who respond.
Intravenous immunoglobulin (IVIG)
Intravenous immunoglobulin has been used in severe, refractory solar urticaria cases with reported benefit in some patients, though the evidence base is limited to case reports and small series. It is generally reserved for individuals who have not responded to antihistamines, omalizumab, or phototherapy.
Epinephrine
Individuals with solar urticaria who have experienced systemic reactions or anaphylaxis — or who have a low minimal urticarial dose indicating high sensitivity — should carry an epinephrine auto-injector (such as an EpiPen, Auvi-Q, or neffy intranasal epinephrine) at all times when outdoors. Epinephrine is the first-line emergency treatment for anaphylaxis and should be used at the first sign of a severe systemic reaction, followed immediately by calling emergency services.
If you are in the NYC area and develop hives rapidly after sun exposure, our allergists can assess whether solar urticaria is the cause and develop a comprehensive management plan including phototesting and appropriate treatment. Book an appointment online or call (212) 686-6321.
Frequently asked questions
How quickly do hives develop in solar urticaria?
Hives typically develop within one to three minutes of light exposure in solar urticaria and almost always within ten minutes. This immediate onset — within the first few minutes of sun contact — is one of the most distinctive features of solar urticaria and what distinguishes it from polymorphous light eruption, which develops hours after exposure. If your hives develop within minutes of stepping into sunlight and resolve within one to two hours of going indoors, solar urticaria is a strong clinical possibility.
Can solar urticaria be triggered indoors?
Yes, in individuals whose action spectrum includes UVA or visible light wavelengths. Standard window glass blocks UVB radiation but transmits most UVA and essentially all visible light. Individuals sensitive to these wavelengths can react while sitting near a window, working in a car, or in environments with strong artificial lighting including fluorescent or LED sources. UV-blocking window film and appropriate photoprotective measures indoors are important for these patients.
Is solar urticaria the same as polymorphous light eruption?
No. Solar urticaria and polymorphous light eruption (PMLE) are distinct conditions. Solar urticaria produces immediate hives within minutes of sun exposure, can cause systemic reactions including anaphylaxis, and is classified as a physical urticaria. PMLE produces a delayed itchy rash appearing hours after sun exposure, does not cause systemic reactions, and tends to improve with repeated sun exposure over the season. The two conditions require different diagnostic approaches and different treatment strategies. See our polymorphous light eruption page for a full overview of PMLE.
Can solar urticaria cause anaphylaxis?
Yes. Solar urticaria is one of the few photosensitivity conditions with the potential to cause anaphylaxis. The risk is most significant when large body surface areas are exposed to light — as occurs during outdoor swimming, sunbathing, or other activities involving significant skin exposure — which produces sufficient systemic histamine release to trigger cardiovascular and respiratory compromise. Individuals with a history of systemic reactions to sun exposure should carry epinephrine and discuss their anaphylaxis risk with an allergist.
Does sunscreen help with solar urticaria?
For individuals whose action spectrum is confined to UVB or UVA wavelengths, broad-spectrum sunscreen can provide meaningful protection. For individuals sensitive to visible light — which standard sunscreens do not block — conventional sunscreen provides little protection and tinted or pigmented products containing iron oxides are needed. Identifying the action spectrum through phototesting is therefore important before recommending sunscreen as a protective measure.
Is solar urticaria curable?
There is no cure for solar urticaria, but spontaneous remission occurs in a proportion of patients over time — studies suggest remission rates of around 15 to 25 percent within five years, with higher rates over longer follow-up periods. In the meantime, effective symptom management through antihistamines, photoprotection, and where needed omalizumab or hardening therapy allows most patients to achieve a reasonable quality of life. Regular follow-up with an allergist allows treatment to be adjusted as the condition evolves.
What is the difference between solar urticaria and heat urticaria?
Solar urticaria is triggered by light — UV or visible wavelengths — rather than heat. Heat urticaria is triggered by direct heat contact with the skin and is a separate form of chronic inducible urticaria. The two can coexist and may both be triggered during sun exposure — the warmth of the sun alongside its light — which can make them difficult to distinguish clinically without phototesting and heat provocation testing. An allergist can perform both tests to determine which trigger is responsible.